Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.

ABSTRACT:

Objective

To evaluate the utility of smartwatch and smartphone-based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

Methods

In the electronic monitoring of disease activity in patients with CIDP (EMDA-CIDP) trial, we performed a prospective observational study from January 2023 to July 2024 at university hospitals in Düsseldorf and Münster, with an independent validation cohort in Hannover. Eligible participants were adults with CIDP on stable intravenous immunoglobulin (IVIG) therapy. Clinical evaluations included established disability scales (I-RODS and INCAT) and quality of life assessments. Activity metrics were captured via consumer-grade smartwatches, with adherence criteri

SUBMITTER: Masanneck L 

PROVIDER: S-EPMC12516250 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature